Upgrade to SI Premium - Free Trial

HELP (HELP)

7.82 -0.28 (3.46%)

Chart
Today 6M 1Y 5Y

Latest Headlines

H.C. Wainwright Reiterates Buy Rating on Helus Pharma (HELP) July 22, 2026 6:52 AM - StreetInsider Form 6-K CYBIN INC. For: Jul 21 July 21, 2026 5:16 PM - SEC Filing Helus Pharma completes enrollment in phase 3 depression study July 21, 2026 10:55 AM - StreetInsider Helus Pharma Completes Enrollment in Phase 3 APPROACH Study of HLP003 in Adjunctive Treatment of Major Depressive Disorder Ahead of Schedule July 21, 2026 10:55 AM - PR NewsWire Helus Pharma completes enrollment in Phase 3 depression study July 21, 2026 7:50 AM - StreetInsider Helus Pharma Completes Enrollment in Phase 3 APPROACH Study of HLP003 in Adjunctive Treatment of Major Depressive Disorder Ahead of Schedule July 21, 2026 7:50 AM - StreetInsider Helus Pharma (HELP) PT Lowered to $45 at Guggenheim July 17, 2026 7:05 AM - StreetInsider Form 6-K CYBIN INC. For: Jun 26 July 16, 2026 3:17 PM - SEC Filing Form D CYBIN INC. July 16, 2026 6:03 AM - SEC Filing Form D CYBIN INC. July 16, 2026 6:03 AM - SEC Filing Helus Pharma (HELP) PT Lowered to $70 at H.C. Wainwright July 9, 2026 6:47 AM - StreetInsider Helus Pharma (HELP) PT Lowered to $42 at Canaccord July 1, 2026 6:34 AM - StreetInsider Multi-Billion-Dollar Battle for the Future of Depression Treatment Has Begun Creating a Huge Opportunity June 30, 2026 9:00 AM - StreetInsider Form 6-K CYBIN INC. For: Jun 29 June 29, 2026 5:10 PM - SEC Filing Helus Pharma reports $148M net loss, closes $50M offering June 29, 2026 7:43 AM - StreetInsider Helus Pharma Reports Recent Business Highlights and Fiscal Year 2026 Financial Results June 29, 2026 7:40 AM - StreetInsider Form 40-F CYBIN INC. For: Mar 31 June 29, 2026 7:36 AM - SEC Filing Form 6-K CYBIN INC. For: Jun 25 June 25, 2026 11:05 AM - SEC Filing Helus Pharma closes $50M share offering at $4.85 per share June 25, 2026 9:52 AM - StreetInsider Helus Pharma™ Announces Closing of US$50 Million Underwritten Offering June 25, 2026 9:28 AM - StreetInsider Form SUPPL CYBIN INC. June 25, 2026 6:02 AM - SEC Filing Form 6-K CYBIN INC. For: Jun 23 June 25, 2026 6:02 AM - SEC Filing Form FWP CYBIN INC. Filed by: CYBIN INC. June 24, 2026 6:02 AM - SEC Filing Helus Pharma prices $50M share offering at $4.85 per share June 24, 2026 6:01 AM - StreetInsider Helus Pharma™ Announces US$50 Million Underwritten Offering June 24, 2026 6:01 AM - Globe NewsWire Helus Pharma™ Announces US$50 Million Underwritten Offering June 24, 2026 6:01 AM - StreetInsider Helus Pharma Phase 3 MDD trial surpasses 86% enrollment June 24, 2026 6:00 AM - StreetInsider Helus Pharma Provides Update on APPROACH Phase 3 Trial Enrollment Progress June 24, 2026 6:00 AM - StreetInsider Form 6-K CYBIN INC. For: Jun 11 June 11, 2026 2:35 PM - SEC Filing Helus Pharma to Participate in the H.C. Wainwright 7th Annual Neuro Perspectives Conference June 11, 2026 7:30 AM - StreetInsider Form 6-K CYBIN INC. For: Jun 01 June 1, 2026 5:24 PM - SEC Filing Helus Pharma to Participate in the Jefferies Global Healthcare Conference in New York June 1, 2026 7:30 AM - StreetInsider Form SCHEDULE 13G/A CYBIN INC. Filed by: Point72 Asset Management, L.P. May 15, 2026 4:33 PM - SEC Filing Form SCHEDULE 13G CYBIN INC. Filed by: Sirenia Capital Management LP May 15, 2026 8:13 AM - SEC Filing Form 6-K CYBIN INC. For: Apr 30 May 4, 2026 4:06 PM - SEC Filing CORRECTION: Helus Pharma Partners with TARA Mind to Advance Veteran Mental Health  April 30, 2026 7:17 PM - Globe NewsWire Form 6-K CYBIN INC. For: Apr 30 April 30, 2026 3:46 PM - SEC Filing Helus Pharma to Participate at the 29th Annual Milken Institute Global Conference April 30, 2026 7:30 AM - Globe NewsWire Form 6-K CYBIN INC. For: Apr 28 April 28, 2026 3:22 PM - SEC Filing Helus Pharma partners with TARA Mind for veteran mental health outreach April 28, 2026 7:32 AM - StreetInsider Helus Pharma Partners with TARA Mind to Advance Veteran Mental Health  April 28, 2026 7:30 AM - StreetInsider Form 6-K CYBIN INC. For: Apr 23 April 23, 2026 7:22 PM - SEC Filing Helus Pharma adds Dr. Robert Langer and Dr. Stephen Brannan to advisory board April 23, 2026 7:30 AM - StreetInsider Helus Pharma Strengthens Scientific Advisory Board with Addition of Dr. Robert Langer and Dr. Stephen Brannan April 23, 2026 7:30 AM - Globe NewsWire Full Article List